• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒刺突蛋白450-650片段的原核表达、重折叠及纯化

Prokaryotic expression, refolding, and purification of fragment 450-650 of the spike protein of SARS-coronavirus.

作者信息

Zhao Jin-Cun, Zhao Zhen-Dong, Wang Wei, Gao Xiao-Ming

机构信息

Department of Immunology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.

出版信息

Protein Expr Purif. 2005 Feb;39(2):169-74. doi: 10.1016/j.pep.2004.10.004.

DOI:10.1016/j.pep.2004.10.004
PMID:15642467
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7129930/
Abstract

The spike (S) glycoprotein is one of the major structure proteins of SARS-associated coronavirus (CoV). Fragment 450-650 (S450-650) of the S protein contains receptor-binding domain and neutralizing epitopes. In this study, S450-650 was expressed with a histidine tag in Escherichia coli BL21. Bacterial inclusion bodies containing the recombinant S450-650 were solubilized with 8 M urea and then applied onto a Ni-nitrilotriacetic acid column. On-column refolding and purification was performed. Reduced glutathione and oxidized glutathione were included in the refolding buffer. In the wash and elution buffers, glycerol and glucose were necessary additives to prevent protein aggregation during purification. This refolding and purification procedure allowed production of S450-650 at up to 500 microg/ml in soluble form, which maintained appropriate antigenicity and immunogenicity. It was able to induce strong IgG responses in BALB/c mice. In Western blot assays, the recombinant S450-650 was recognized by monoclonal Ab against the His-tag and also sera from a convalescent SARS patient. S450-650-based ELISA system was able to detect anti-SARS-CoV IgG Abs in patient sera.

摘要

刺突(S)糖蛋白是严重急性呼吸综合征相关冠状病毒(CoV)的主要结构蛋白之一。S蛋白的450-650片段(S450-650)包含受体结合结构域和中和表位。在本研究中,S450-650在大肠杆菌BL21中以带有组氨酸标签的形式表达。含有重组S450-650的细菌包涵体用8 M尿素溶解,然后应用于镍-次氮基三乙酸柱。进行柱上复性和纯化。复性缓冲液中包含还原型谷胱甘肽和氧化型谷胱甘肽。在洗涤和洗脱缓冲液中,甘油和葡萄糖是防止纯化过程中蛋白质聚集的必要添加剂。这种复性和纯化程序能够以高达500μg/ml的可溶性形式生产S450-650,其保持了适当的抗原性和免疫原性。它能够在BALB/c小鼠中诱导强烈的IgG反应。在蛋白质印迹分析中,重组S450-650被抗组氨酸标签的单克隆抗体以及一名SARS康复患者的血清识别。基于S450-650的ELISA系统能够检测患者血清中的抗SARS-CoV IgG抗体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f69/7129930/72724d0ff48b/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f69/7129930/ee3c861de634/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f69/7129930/230b9ee4a8cd/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f69/7129930/9130f93888d9/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f69/7129930/02192330fd1f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f69/7129930/fb9be5deca8c/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f69/7129930/72724d0ff48b/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f69/7129930/ee3c861de634/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f69/7129930/230b9ee4a8cd/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f69/7129930/9130f93888d9/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f69/7129930/02192330fd1f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f69/7129930/fb9be5deca8c/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f69/7129930/72724d0ff48b/gr6.jpg

相似文献

1
Prokaryotic expression, refolding, and purification of fragment 450-650 of the spike protein of SARS-coronavirus.严重急性呼吸综合征冠状病毒刺突蛋白450-650片段的原核表达、重折叠及纯化
Protein Expr Purif. 2005 Feb;39(2):169-74. doi: 10.1016/j.pep.2004.10.004.
2
A study on antigenicity and receptor-binding ability of fragment 450-650 of the spike protein of SARS coronavirus.严重急性呼吸综合征冠状病毒刺突蛋白450-650片段的抗原性及受体结合能力研究
Virology. 2007 Mar 15;359(2):362-70. doi: 10.1016/j.virol.2006.09.022. Epub 2006 Oct 20.
3
Development and evaluation of an enzyme-linked immunosorbent assay for detection of antibodies against the spike protein of SARS-coronavirus.一种用于检测抗严重急性呼吸综合征冠状病毒刺突蛋白抗体的酶联免疫吸附测定法的开发与评估
J Clin Virol. 2005 May;33(1):12-8. doi: 10.1016/j.jcv.2004.09.024.
4
Calreticulin as a hydrophilic chimeric molecular adjuvant enhances IgG responses to the spike protein of severe acute respiratory syndrome coronavirus.钙网织蛋白作为一种亲水嵌合分子佐剂增强了对严重急性呼吸综合征冠状病毒刺突蛋白的 IgG 应答。
Microbiol Immunol. 2012 Aug;56(8):554-61. doi: 10.1111/j.1348-0421.2012.00467.x.
5
Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies.严重急性呼吸综合征冠状病毒刺突蛋白的受体结合域包含多个构象依赖性表位,这些表位可诱导产生高效中和抗体。
J Immunol. 2005 Apr 15;174(8):4908-15. doi: 10.4049/jimmunol.174.8.4908.
6
[Receptor-binding ability of fragments 260-600 and 397-796 of SARS-associated coronavirus spike protein].[严重急性呼吸综合征相关冠状病毒刺突蛋白片段260 - 600和397 - 796的受体结合能力]
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2005 Dec;19(4):353-7.
7
Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein.重组严重急性呼吸综合征冠状病毒刺突蛋白的抗原性及受体结合能力
Biochem Biophys Res Commun. 2004 Jan 23;313(4):938-47. doi: 10.1016/j.bbrc.2003.11.180.
8
[Prokaryotic expression of SARS coronavirus spike protein and construction of its DNA vaccine].[严重急性呼吸综合征冠状病毒刺突蛋白的原核表达及其DNA疫苗的构建]
Di Yi Jun Yi Da Xue Xue Bao. 2005 Jan;25(1):33-6.
9
Preparation and characterization of monoclonal antibodies against S1 domain at N-terminal residues 249 to 667 of SARS-associated coronavirus S1 protein.针对严重急性呼吸综合征相关冠状病毒S1蛋白N端249至667位残基的S1结构域的单克隆抗体的制备与鉴定
Di Yi Jun Yi Da Xue Xue Bao. 2004 Jan;24(1):1-6.
10
SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus.以来自大肠杆菌的重组刺突多肽作为加强剂的严重急性呼吸综合征冠状病毒刺突多肽DNA疫苗初免可诱导产生高滴度的抗严重急性呼吸综合征冠状病毒中和抗体。
Vaccine. 2005 Oct 10;23(42):4959-68. doi: 10.1016/j.vaccine.2005.05.023.

引用本文的文献

1
Enhancing neutralizing antibodies against receptor binding domain of SARS-CoV-2 by a safe natural adjuvant system.通过安全的天然佐剂系统增强针对 SARS-CoV-2 受体结合域的中和抗体。
Virus Res. 2023 Mar;326:199047. doi: 10.1016/j.virusres.2023.199047. Epub 2023 Jan 21.
2
Unglycosylated Soluble SARS-CoV-2 Receptor Binding Domain (RBD) Produced in Combined with the Army Liposomal Formulation Containing QS21 (ALFQ) Elicits Neutralizing Antibodies against Mismatched Variants.与含QS21的陆军脂质体制剂(ALFQ)联合产生的未糖基化可溶性严重急性呼吸综合征冠状病毒2(SARS-CoV-2)受体结合域(RBD)可引发针对不匹配变体的中和抗体。
Vaccines (Basel). 2022 Dec 25;11(1):42. doi: 10.3390/vaccines11010042.
3

本文引用的文献

1
An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies.严重急性呼吸综合征冠状病毒刺突蛋白中的一个暴露结构域可诱导中和抗体。
J Virol. 2004 Jul;78(13):7217-26. doi: 10.1128/JVI.78.13.7217-7226.2004.
2
Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association.一种针对S1蛋白的人源单克隆抗体可有效中和严重急性呼吸综合征(SARS)冠状病毒,该抗体可阻断受体结合。
Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2536-41. doi: 10.1073/pnas.0307140101.
3
Expression cloning of functional receptor used by SARS coronavirus.
Amyloid fibrillation of the glaucoma associated myocilin protein is inhibited by epicatechin gallate (ECG).
表没食子儿茶素没食子酸酯(ECG)可抑制青光眼相关肌纤蛋白的淀粉样纤维化。
RSC Adv. 2022 Oct 14;12(45):29469-29481. doi: 10.1039/d2ra05061g. eCollection 2022 Oct 11.
4
COVID-19 immunotherapy: Treatment based on the immune cell-mediated approaches.COVID-19 免疫疗法:基于免疫细胞介导方法的治疗。
Int Immunopharmacol. 2022 Jun;107:108655. doi: 10.1016/j.intimp.2022.108655. Epub 2022 Feb 25.
5
A universal bacteriophage T4 nanoparticle platform to design multiplex SARS-CoV-2 vaccine candidates by CRISPR engineering.一种通过CRISPR工程设计多重SARS-CoV-2候选疫苗的通用噬菌体T4纳米颗粒平台。
Sci Adv. 2021 Sep 10;7(37):eabh1547. doi: 10.1126/sciadv.abh1547. Epub 2021 Sep 8.
6
Expression of SARS-CoV-2 surface glycoprotein fragment 319-640 in E. coli, and its refolding and purification.SARS-CoV-2 表面糖蛋白片段 319-640 在大肠杆菌中的表达、复性及纯化。
Protein Expr Purif. 2021 Jul;183:105861. doi: 10.1016/j.pep.2021.105861. Epub 2021 Mar 2.
7
DCs-based therapies: potential strategies in severe SARS-CoV-2 infection.基于树突状细胞的疗法:严重 SARS-CoV-2 感染的潜在策略。
Int J Med Sci. 2021 Jan 1;18(2):406-418. doi: 10.7150/ijms.47706. eCollection 2021.
8
Cell adhesion as a novel approach to determining the cellular binding motif on the severe acute respiratory syndrome coronavirus spike protein.细胞黏附作为一种新方法,用于确定严重急性呼吸综合征冠状病毒刺突蛋白上的细胞结合基序。
J Virol Methods. 2014 Jun;201:1-6. doi: 10.1016/j.jviromet.2014.01.022. Epub 2014 Feb 13.
9
Calreticulin as a hydrophilic chimeric molecular adjuvant enhances IgG responses to the spike protein of severe acute respiratory syndrome coronavirus.钙网织蛋白作为一种亲水嵌合分子佐剂增强了对严重急性呼吸综合征冠状病毒刺突蛋白的 IgG 应答。
Microbiol Immunol. 2012 Aug;56(8):554-61. doi: 10.1111/j.1348-0421.2012.00467.x.
10
Comparison of immunoglobulin G responses to the spike and nucleocapsid proteins of severe acute respiratory syndrome (SARS) coronavirus in patients with SARS.严重急性呼吸综合征(SARS)患者针对SARS冠状病毒刺突蛋白和核衣壳蛋白的免疫球蛋白G反应比较
Clin Vaccine Immunol. 2007 Jul;14(7):839-46. doi: 10.1128/CVI.00432-06. Epub 2007 May 2.
严重急性呼吸综合征冠状病毒所使用的功能性受体的表达克隆
Biochem Biophys Res Commun. 2004 Mar 5;315(2):439-44. doi: 10.1016/j.bbrc.2004.01.076.
4
Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein.重组严重急性呼吸综合征冠状病毒刺突蛋白的抗原性及受体结合能力
Biochem Biophys Res Commun. 2004 Jan 23;313(4):938-47. doi: 10.1016/j.bbrc.2003.11.180.
5
In vitro protein refolding by chromatographic procedures.
Protein Expr Purif. 2004 Jan;33(1):1-10. doi: 10.1016/j.pep.2003.08.023.
6
On-column purification and refolding of recombinant bovine prion protein: using its octarepeat sequences as a natural affinity tag.重组牛朊蛋白的柱上纯化与复性:利用其八肽重复序列作为天然亲和标签
Protein Expr Purif. 2003 Nov;32(1):104-9. doi: 10.1016/S1046-5928(03)00195-5.
7
The secret life of ACE2 as a receptor for the SARS virus.血管紧张素转换酶2(ACE2)作为严重急性呼吸综合征(SARS)病毒受体的隐秘功能
Cell. 2003 Dec 12;115(6):652-3. doi: 10.1016/s0092-8674(03)00976-0.
8
A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2.严重急性呼吸综合征冠状病毒S蛋白的一个193个氨基酸的片段可有效结合血管紧张素转换酶2。
J Biol Chem. 2004 Jan 30;279(5):3197-201. doi: 10.1074/jbc.C300520200. Epub 2003 Dec 11.
9
The SARS-CoV S glycoprotein: expression and functional characterization.严重急性呼吸综合征冠状病毒S糖蛋白:表达与功能特性
Biochem Biophys Res Commun. 2003 Dec 26;312(4):1159-64. doi: 10.1016/j.bbrc.2003.11.054.
10
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.血管紧张素转换酶2是严重急性呼吸综合征冠状病毒的功能性受体。
Nature. 2003 Nov 27;426(6965):450-4. doi: 10.1038/nature02145.